Preferred Label : alosetron;
CISMeF synonym : GR 68755; lotronex; GlaxoSmithKline brand of alosetron hydrochloride;
MeSH hyponym : alosetron monohydrochloride; 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one
monohydrochloride; GR68755;
MeSH CAS label : 1H-pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-;
MeSH Related Number : alosetron hydrochloride; 122852-42-0 (alosetron); 122852-69-1 (mono-HCl); 2F5R1A46YW;
Registry Number MeSH : 122852-42-0;
Related CAS MeSH : 122852-69-1 (alosetron hydrochloride);
related registry number list (CISMeF) : 122852-69-1 (mono-HCl);
Is substance : O;
UNII : 13Z9HTH115;
InChIKey : JSWZEAMFRNKZNL-UHFFFAOYSA-N;
Origin ID : C090840;
UMLS CUI : C0291772;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.cadth.ca/sites/default/files/pdf/133_lotronex_cetap_e.pdf
https://www.cadth.ca/sites/default/files/pdf/133_lotronex_cetap_f.pdf
2000
Canada
French
English
alosetron
alosetron
irritable bowel syndrome
gastrointestinal agents
serotonin antagonists
carbolines
treatment outcome
canada
Evidence-Based medicine
administration, oral
united states
diarrhea
carbolines
gastrointestinal agents
serotonin antagonists
clinical trials as topic
alosetron
carbolines
drug evaluation
---